Metabolic Effects of Whey Protein Supplementation After Fasting in Volunteers

NCT ID: NCT05656339

Last Updated: 2022-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-01

Study Completion Date

2023-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the early metabolic effects and acute phase response of an oral clear supplement containing whey protein plus carbohydrates in young healthy volunteers during fasting-induced organic response

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will enroll young male healthy volunteers. In this controlled crossover clinical trial, after a 12-hour fast, subjects will be randomized to consumed either: a) 200ml of carbohydrates enriched with whey protein (CHO+WP; n=30); or b) 200ml of water plus maltodextrin (CHO group, n=30); or c) remained fasting (Fast group; n=30). Blood samples will be collected after 12h-fast and three hours after the ingestion of the supplements (or 3h fast in Fast group) for blood glucose; glycated hemoglobin; serum insulin; C-reactive protein; beta-hydroxybutyrate; triglycerides; albumin; chlorine and sodium assays. After a temporal break of seven days an inversion of the groups will performed so all subjects entered in the three groups. Group CHO+P will drink a clear non-residual supplement (698 mOsm/L) having 100% whey protein isolated from total proteins, with various vitamins (B1, B6, C, D, niacin and folic acid) with a "lemon tea" flavor (Nutren Fresh; Nestlé, São Paulo, Brazil). The formula contains no lactose or lipids; is formulated with a volume of 200ml, with a caloric density of 1.28kcal/ml; protein: 10g in 200ml of the product (100% whey protein isolate); and carbohydrate: 54g in 200ml of the product (74% glucose syrup and 26% maltodextrin); Group CHO will received a clear supplement containing 200 mL of water combined with unflavored 25 g of 100% maltodextrin (CarboCH - Prodiet, Curitiba, Brazil) at 12.5% dilution (101 mOsm/kg; 95kcal/200ml). The third group (Fast group; n=10) will not consume any food or supplement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ketosis Acute-Phase Response Insulin Resistance

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Ketone bodies Whey protein Fasting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Male volunteers, aged between 18 and 27 years, healthy, with no report of acute illness during 3 months prior to the study will be included. Individuals with obesity (calculated body mass index above 30 kg/m2), those who reported consumption of alcoholic beverages or any nutritional supplement during the study period will be excluded. The 30 selected volunteers will be scheduled to came to the laboratory after an overnight fast of 12 hours. Participants in the fasting group will immediately collect blood samples. The CHO and the CHO+WP groups will drink 200 ml of the respective supplements described above. After an interval of three hours after ingestion of the supplement, blood samples will be collected again for biochemical assays.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Outcomes Assessor will not know the randomization nor the phases of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

12 hours Fast - Fast Group

Participants will proceed in 12 hours fast condition for blood collection for laboratory assays

Group Type SHAM_COMPARATOR

Fast

Intervention Type DIETARY_SUPPLEMENT

Fast condition of 12 hours

Carbohydrate plus whey protein supplement - CHO+WP group

After 12 hours fast participants will collect blood samples and immediately will drink an oral supplement containing carbohydrates plus whey protein. After 3 hours of ingesting the supplement blood samples will be collected again

Group Type ACTIVE_COMPARATOR

CHO+WP

Intervention Type DIETARY_SUPPLEMENT

Oral supplement containing carbohydrates plus whey protein

Carbohydrate supplement - CHO group

After 12 hours fast participants will collect blood samples and immediately will drink an oral supplement containing carbohydrates alone without whey protein. After 3 hours of ingesting the supplement blood samples will be collected again

Group Type PLACEBO_COMPARATOR

CHO

Intervention Type DIETARY_SUPPLEMENT

Oral supplement containing carbohydrates

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CHO+WP

Oral supplement containing carbohydrates plus whey protein

Intervention Type DIETARY_SUPPLEMENT

CHO

Oral supplement containing carbohydrates

Intervention Type DIETARY_SUPPLEMENT

Fast

Fast condition of 12 hours

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male young healthy volunteers

Exclusion Criteria

* Individuals with obesity (calculated body mass index above 30 kg/m2)
* Participants reporting consumption of alcoholic beverages
* Consumption of any nutritional supplement during the study period
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Univag Centro Universitário

OTHER

Sponsor Role collaborator

Federal University of Mato Grosso

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

José Eduardo de Aguilar-Nascimento, MD, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose E Nascimento, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Univag Centro Universitário

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centro Universitário de Varzea Grande (UNIVAG)

Várzea Grande, Mato Grosso, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jose Nascimento, MD, PhD

Role: CONTACT

Phone: +5565999815388

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thais C Dombroski, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

42481121.3.0000.5692

Identifier Type: -

Identifier Source: org_study_id